Treatment of tumors with autologous lak cells, interleukin-2...

Details Treatment of tumors with autologous lak cells, interleukin-2... Treatment of tumors with autologous lak cells, interleukin-2...

A - Human Necessities

61

K

167/103.2

A61K 31/195 (2006.01) A61K 31/13 (2006.01) A61K 38/20 (2006.01)

Patent

CA 1318586

ABSTRACT Ornithine decarboxylase inhibitors when administered in conjunction with autologous LAK cells and interleukin-2 provide for an enhanced treatment of neoplastic disease states. This enhancement is provided by the ability of an ornithine decarboxylase inhibitor to reduce tumor load and to enhance interleukin-2 production in T helper cells. C-35,155

536385

Affiliated with

Also associated with

Rating

Treatment of tumors with autologous lak cells, interleukin-2... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of tumors with autologous lak cells, interleukin-2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of tumors with autologous lak cells, interleukin-2... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1237415